Abstract
AbstractOlder adults (≥65 years of age) bear a significant burden of severe disease and mortality associated with influenza, despite relatively high annual vaccination coverage and substantial pre-existing immunity to influenza. To test the hypothesis that host factors, including age and sex, play a role in determining the effect of repeated vaccination and levels of pre-existing humoral immunity to influenza, we evaluated pre- and post-vaccination strain-specific hemagglutination inhibition (HAI) titers in adults over 75 years of age who received a high-dose influenza vaccine in at least four out of six influenza seasons. Pre-vaccination titers, rather than host factors and repeated vaccination were significantly associated with post-vaccination HAI titer outcomes, and displayed an age-by-sex interaction. Pre-vaccination titers to H1N1 remained constant with age. Titers to H3N2 and influenza B viruses decreased substantially with age in males, whereas titers in females remained constant with age. Our findings highlight the importance of pre-existing immunity in this highly vaccinated older adult population and suggest that older males are particularly vulnerable to reduced pre-existing humoral immunity to influenza.
Funder
U.S. Department of Health & Human Services | NIH | National Institute on Aging
Fonds de Recherche du Québec - Santé
Paul Milstein Program for Senior Health
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology
Reference71 articles.
1. Macias, A. E. et al. The disease burden of influenza beyond respiratory illness. Vaccine https://doi.org/10.1016/j.vaccine.2020.09.048 (2020).
2. Iuliano, A. D. et al. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 391, 1285–1300 (2018).
3. Global Burden of Disease Influenza Collaborators. et al. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir. Med. 7, 69–89 (2018). PMID - 30553848.
4. Gnanasekaran, G., Biedenbender, R., Davidson, H. E. & Gravenstein, S. Vaccinations for the Older Adult. Clin. Geriatr. Med 32, 609–625 (2016).
5. Hamborsky, J., Kroger, A. & Wolfe, S. Epidemiology and prevention of vaccine-preventable diseases. (US Department of Health & Human Services, Centers for Disease Control and Prevention 2015).